The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
Open accessAbstract
OBJECTIVE: To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: Are nonsteroidal anti-inflammatory drugs (NSAIDs) or other complementary treatments effective for migraine prevention? METHODS: The authors analyzed published studies from June 1999 to May 2009 using a structured review process to classify the evidence relative to the efficacy of various medications for migraine prevention. RESULTS: The author panel reviewed 284 abstracts, which ultimately yielded 49 Class I or Class II articles on migraine prevention; of these 49, 15 were classified as involving nontraditional therapies, NSAIDs, and other complementary therapies that are reviewed herein. RECOMMENDATIONS: Petasites (butterbur) is effective for migraine prevention and should be offered to patients with migraine to reduce the frequency and severity of migraine attacks (Level A). Fenoprofen, ibuprofen, ketoprofen, naproxen, naproxen sodium, MIG-99 (feverfew), magnesium, riboflavin, and subcutaneous histamine are probably effective for migraine prevention (Level B). Treatments considered possibly effective are cyproheptadine, Co-Q10, estrogen, mefenamic acid, and flurbiprofen (Level C). Data are conflicting or inadequate to support or refute use of aspirin, indomethacin, omega-3, or hyperbaric oxygen for migraine prevention. Montelukast is established as probably ineffective for migraine prevention (Level B).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Self-citationSilberstein, S. D. (2000) · Neurology · doi:10.1212/wnl.55.6.754 · Cited by 1,360
Self-citationSilberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
Self-citationDiamond, S., Bigal, M. E., Silberstein, S., Loder, E., Reed, M., & Lipton, R. B. (2007) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00631.x · Cited by 413
Self-citationEfficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., Magis, D., Seidel, L., Agosti, R. M., & Schoenen, J. (2005) · Neurology · doi:10.1212/01.wnl.0000151975.03598.ed · Cited by 371
Petasites hybridus root (butterbur) is an effective preventive treatment for migraine
Lipton, R. B., Göbel, H., Einhäupl, K. M., Wilks, K., & Mauskop, A. (2004) · Neurology · doi:10.1212/01.wnl.0000147290.68260.11 · Cited by 254
Pfaffenrath, V, Diener, H., Fischer, M., Friede, M., & Henneicke-von Zepelin, H. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00396.x · Cited by 180
A Combination of Riboflavin, Magnesium, and Feverfew for Migraine Prophylaxis: A Randomized Trial
Maizels, M., Blumenfeld, A., & Burchette, R. (2004) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2004.04170.x · Cited by 178
Diener, H., Pfaffenrath, V, Schnitker, J., Friede, M., Zepelin, H.-H. H.-V., & on behalf of the Investigators (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00950.x · Cited by 160
Prevention of menstrual attacks of migraine
MacGregor, E. A., Frith, A., Ellis, J. E., Aspinall, L., & Hackshaw, A. K. (2006) · Neurology · doi:10.1212/01.wnl.0000249114.52802.55 · Cited by 154
Cited by
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
Orofacial pain management: current perspectives
Romero-Reyes, M., & Uyanik, J. M. (2014) · Journal of Pain Research · doi:10.2147/jpr.s37593 · Cited by 303
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study
Adelborg, K., Szépligeti, S. K., Holland-Bill, L., Ehrenstein, V., Horváth-Puhó, E., Henderson, V. W., & Sørensen, H. T. (2018) · BMJ · doi:10.1136/bmj.k96 · Cited by 301
Silberstein, S. D. (2015) · Continuum · doi:10.1212/con.0000000000000199 · Cited by 278
Self-citationProphylaxis of migraine headaches with riboflavin: A systematic review
Thompson, D. F., & Saluja, H. S. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12548 · Cited by 101
Metadata
- Authors
- Holland, S., Silberstein, S. D., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E.
- Venue
- Neurology
- Published
- 2012-04-24
- Volume
- 78
- Issue
- 17
- Pages
- 1346-1353
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2168033298
- Cited by
- 347
- References
- 23
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. https://app.cochat.ai/papers/10.1212/wnl.0b013e3182535d0c
- The paper
- Holland, S., Silberstein, S. D., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012). Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. https://doi.org/10.1212/wnl.0b013e3182535d0c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.